Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Table 1 from Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Home
Publications
Supplementary Table 1 from Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Supplementary Table 1 from Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
Authors:
WX
Wenjie Xiong
Wenjie Xiong
YY
Yuting Yan
Yuting Yan
TW
Tingyu Wang
Tingyu Wang
WS
Weiwei Sui
Weiwei Sui
YY
Ying Yu
Ying Yu
TY
Tengteng Yu
Tengteng Yu
RL
Rui Lyu
Rui Lyu
YW
Yi Wang
Yi Wang
WL
Wei Liu
Wei Liu
HL
Huimin Liu
Huimin Liu
GA
Gang An
Gang An
YX
Yan Xu
Yan Xu
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
15 May 2025
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1078-0432.29072458
Abstract
Supplementary Table 1. Representativeness of Study Participants.
Keywords
CLINICAL TRIAL RESULTS
DRUG TARGETS
HEMATOLOGICAL CANCERS
LYMPHOMAS
Related articles
Scroll to top